Problems in pharmacoeconomic analyses - Reply

被引：0

|

作者：

Rennie, D ^{[1
]}

Luft, HS ^{[1
]}

机构：

[1] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2000年 / 284卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1924 / 1924

页数：1

相关论文

共 50 条

[1] Common errors and controversies in pharmacoeconomic analyses - Reply
Palmer, S
Byford, S
PHARMACOECONOMICS, 1998, 14 (06) : 712 - 714
[2] HOW MUCH FAITH CAN WE HAVE IN PHARMACOECONOMIC ANALYSES - REPLY
BENTKOVER, JD
PHARMACOECONOMICS, 1994, 6 (06) : 585 - 586
[3] Problems with the interpretation of pharmacoeconomic analyses - A review of submissions to the Australian pharmaceutical benefits scheme
Hill, SR
Mitchell, AS
Henry, DA
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (16): : 2116 - 2121
[4] How to improve your pharmacoeconomic analyses with sensitivity analyses
Basskin, L
FORMULARY, 1997, 32 (08) : 842 - &
[5] Methodological hurdles in conducting pharmacoeconomic analyses
Rizzo, JD
Powe, NR
PHARMACOECONOMICS, 1999, 15 (04) : 339 - 355
[6] Published pharmacoeconomic analyses: science or marketing?
Henry, D
Lang, D
INTERNAL MEDICINE JOURNAL, 2003, 33 (9-10) : 403 - 404
[7] Pharmacoeconomic analyses make way into oncology
Amber, D
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (15) : 1204 - 1205
[8] Common errors and controversies in pharmacoeconomic analyses
Byford, S
Palmer, S
PHARMACOECONOMICS, 1998, 13 (06) : 659 - 666
[9] Common errors and controversies in pharmacoeconomic analyses
Soto, J
PHARMACOECONOMICS, 1998, 14 (06) : 711 - 712
[10] Methodological hurdles in conducting pharmacoeconomic analyses
Rizzo J.D.
Powe N.R.
PharmacoEconomics, 1999, 15 (4) : 339 - 355

← 1 2 3 4 5 →